Michael Hochman, MD, MPH, board certified general internist at USC’s Keck School of Medicine, cofounder of Updates in Slow Medicine, and host of the Healthy Skeptic, MD podcast,…
Pharmacomechanical thrombolysis can be particularly effective in mitigating post-thrombotic syndrome (PTS) in younger patients, as demonstrated by data from the ATTRACT trial.
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Epstein-Barr virus (EBV), similar to other common viruses, remains in the body indefinitely after exposure and requires constant monitoring by the immune system in order to effectively to…
Dr. Carolina Horta Andrade, Ph.D., adjunct professor at the Federal University of Goiás in Brazil and the lead researcher on the #OpenZika project on IBM’s World Community Grid,…
With the Olympics in Rio de Janeiro about to begin, now seems like a good time to revisit the available information on Zika virus. While studies on potential…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Precision medicine aims to tailor medical treatments to each patient’s individual genetic profile and biology. Cancer researchers know that patients with particular mutations may respond better to certain…
A certain bioactive polyphenol found in pomegranates reacts with bacteria in the gut to produce urolithin A, a compound with potential life-extending properties.
With over 5 million people suffering from Alzheimer’s disease in the United States, finding viable treatments has become a top priority. However, only four drugs targeting this disease…
